New drug duo tested against advanced cancers
NCT ID NCT05021120
First seen Jan 06, 2026 · Last updated Apr 29, 2026 · Updated 19 times
Summary
This early-phase study tested a new combination of two drugs, AK127 and AK104, in 67 people with advanced or metastatic solid tumours that had stopped responding to other treatments. The main goal was to check safety and find the right dose, while also looking at whether the tumours shrank. The study is now complete.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED OR METASTATIC SOLID TUMOURS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ashford Cancer Centre Research
Adelaide, Australia
-
Austin Health
Melbourne, Australia
-
Monash Health
Melbourne, Australia
-
Southside Cancer Care Centre
Sydney, Australia
-
The Kinghorn Cancer Centre, St Vincents Hospital Sydney
Sydney, Australia
Conditions
Explore the condition pages connected to this study.